BenevolentAI's latest financing could halve its $2B valuation — and that has Woodford watchers worried
BenevolentAI is barely clinging to its unicorn status after its latest round of financing from Singapore’s Temasek, which would reportedly halve its $2 billion valuation — and deal another blow to troubled fund manager Neil Woodford.
Temasek will take a minority stake in a deal that values London-based BenevolentAI at $1 billion, the Sunday Times reported. A $115 million financing round last April — dedicated in part to scaling its drug development work — had donned a pre-money valuation of $2 billion.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.